Handbook of HER2-Targeted Agents in Breast Cancer / by Ricardo H Alvarez, Javier Cortés, Mary Falzon, Michael Gandy, Luca Gianni, Nadia Harbeck, Martine Piccart
By: Alvarez, Ricardo H.
Contributor(s): Cortés, Javier.
| Falzon, Mary
| Gandy, Michael
| Gianni, Luca
| Harbeck, Nadia.
| Piccart, Martine.
| SpringerLink (Online service)
Material type:
E-bookPublisher: Cham : Springer International Publishing Imprint Adis, 2016Edition: 2nd ed.Description: 1 recurso en línea (XI, 110 páginas) : 17 ilustraciones, 16 ilustraciones en color.ISBN: 9783319282169.Subject: Cerebro -- Tumores
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC280.B8 H35 2016 EB (Browse shelf(Opens below)) | .i11613750 | Acceso electrónico | eBOOK .i11613750 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| No cover image available | ||||||||
| RC280 .B8 ES Breast Cancer : Basic and Clinical Research | RC280.B8 F468 2017 EB Male breast cancer | RC280.B8 .G46 2017 EB Breast cancer : innovations in research and management | RC280.B8 H35 2016 EB Handbook of HER2-Targeted Agents in Breast Cancer | RC280.B8 H356 2013 EB Light Pollution as a New Risk Factor for Human Breast and Prostate Cancers | RC280.B8 I477 2015 EB Improving Outcomes for Breast Cancer Survivors : Perspectives on Research Challenges and Opportunities | RC280.B8 M563 2016 EB Breast Cancer Prevention and Treatment |
Introduction and background biology -- HER2 testing -- HER2-positive breast cancer: neoadjuvant and adjuvant therapy -- HER2-positive metastatic breast cancer: first-line treatment -- HER2-positive metastatic breast cancer: second-line treatment -- Emerging targeted agents for HER2-positive breast cancer.
This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.
There are no comments on this title.